Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Inhibition of JNK by cellular stress- and tumor necrosis factor α-induced AKT2 through activation of the NFκB pathway in human epithelial cells.

Yuan ZQ, Feldman RI, Sun M, Olashaw NE, Coppola D, Sussman GE, Shelley SA, Nicosia SV, Cheng JQ.

J Biol Chem. 2016 Oct 21;291(43):22849. No abstract available.

2.

SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities.

Peng L, Yuan Z, Ling H, Fukasawa K, Robertson K, Olashaw N, Koomen J, Chen J, Lane WS, Seto E.

Mol Cell Biol. 2011 Dec;31(23):4720-34. doi: 10.1128/MCB.06147-11. Epub 2011 Sep 26.

3.

Deacetylation of cortactin by SIRT1 promotes cell migration.

Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, Kruk PA, Cheng JQ, Bai W, Chen J, Nicosia SV, Zhang X.

Oncogene. 2009 Jan 22;28(3):445-60. doi: 10.1038/onc.2008.388. Epub 2008 Oct 13.

PMID:
18850005
4.

SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress.

Yang Y, Fu W, Chen J, Olashaw N, Zhang X, Nicosia SV, Bhalla K, Bai W.

Nat Cell Biol. 2007 Nov;9(11):1253-62. Epub 2007 Oct 14. Erratum in: Nat Cell Biol. 2007 Dec;9(12):1442.

5.

HDAC6 modulates cell motility by altering the acetylation level of cortactin.

Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N, Parsons JT, Yang XJ, Dent SR, Yao TP, Lane WS, Seto E.

Mol Cell. 2007 Jul 20;27(2):197-213.

6.

ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).

Epling-Burnette PK, Bai F, Wei S, Chaurasia P, Painter JS, Olashaw N, Hamilton A, Sebti S, Djeu JY, Loughran TP.

Oncogene. 2004 Dec 9;23(57):9220-9.

PMID:
15516985
7.
8.

Molecular cloning and functional characterization of the transcription factor YY2.

Nguyen N, Zhang X, Olashaw N, Seto E.

J Biol Chem. 2004 Jun 11;279(24):25927-34. Epub 2004 Apr 15.

9.

AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1.

Savell J, Ma Y, Morrow KS, Jove R, Olashaw N, Moseley PL, Cress WD, Wharton W.

Mol Cancer Ther. 2004 Feb;3(2):205-13.

10.

Cell cycle control: a complex issue.

Olashaw N, Bagui TK, Pledger WJ.

Cell Cycle. 2004 Mar;3(3):263-4. Epub 2004 Mar 1.

PMID:
14726706
11.

Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-kappa B (RelB/p50) in myeloma cells.

Landowski TH, Olashaw NE, Agrawal D, Dalton WS.

Oncogene. 2003 Apr 24;22(16):2417-21.

PMID:
12717418
12.

Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells.

Yuan ZQ, Feldman RI, Sun M, Olashaw NE, Coppola D, Sussman GE, Shelley SA, Nicosia SV, Cheng JQ.

J Biol Chem. 2002 Aug 16;277(33):29973-82. Epub 2002 Jun 4. Retraction in: J Biol Chem. 2016 Oct 21;291(43):22849.

13.

Paradigms of growth control: relation to Cdk activation.

Olashaw N, Pledger WJ.

Sci STKE. 2002 May 28;2002(134):re7. Review.

PMID:
12034920
14.
15.
16.
17.

Constitutive RelB activation in v-Src-transformed fibroblasts: requirement for IkappaB degradation.

Shain KH, Jove R, Olashaw NE.

J Cell Biochem. 1999 May 1;73(2):237-47.

PMID:
10227387
18.

Transactivation by expression of the hepatitis B virus X protein with an inducible system.

Azizan A, Cong YS, Shain K, Tsai SC, Yao YL, Olashaw N, Seto E.

Mol Biol Rep. 1998 Nov;25(4):231-6.

PMID:
9870613
19.

Inducible activation of RelB in fibroblasts.

Olashaw NE.

J Biol Chem. 1996 Nov 29;271(48):30307-10.

21.

Characterization of platelet-derived growth factor alpha receptor synthesis and metabolic turnover.

Coats SR, Olashaw NE, Pledger WJ.

Cell Growth Differ. 1994 Sep;5(9):937-42.

22.

Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts.

Olashaw NE, Kowalik TF, Huang ES, Pledger WJ.

Mol Biol Cell. 1992 Oct;3(10):1131-9.

23.
24.

Biochemical and functional discrimination of platelet-derived growth factor alpha and beta receptors in BALB/c-3T3 cells.

Olashaw NE, Kusmik W, Daniel TO, Pledger WJ.

J Biol Chem. 1991 Jun 5;266(16):10234-40.

26.

Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells.

Wahl MI, Olashaw NE, Nishibe S, Rhee SG, Pledger WJ, Carpenter G.

Mol Cell Biol. 1989 Jul;9(7):2934-43.

27.
29.

Cellular mechanisms regulating proliferation.

Olashaw NE, Pledger WJ.

Adv Second Messenger Phosphoprotein Res. 1988;22:139-73. Review. No abstract available.

PMID:
2852022
30.

Control of late G0/G1 progression and protein modification by SmC/IGF I.

Olashaw NE, Van Wyk JJ, Pledger WJ.

Am J Physiol. 1987 Oct;253(4 Pt 1):C575-9.

PMID:
3310654
31.

Heterologous regulation of EGF receptors in fibroblastic cells.

Olashaw NE, Pledger WJ.

J Cell Biochem. 1987 Jun;34(2):143-9.

PMID:
3496345
32.
33.
34.

Differential sensitivity of fibroblasts to epidermal growth factor is related to cyclic AMP concentration.

Olashaw NE, Leof EB, O'Keefe EJ, Pledger WJ.

J Cell Physiol. 1984 Mar;118(3):291-7.

PMID:
6321523
35.

Mechanisms initiating cellular proliferation.

Olashaw NE, Pledger WJ.

Symp Fundam Cancer Res. 1984;37:31-44. No abstract available.

PMID:
6528127
36.

Thymidine triphosphate synthesis in senescent WI38 cells. Relationship to loss of replicative capacity.

Olashaw NE, Kress ED, Cristofalo VJ.

Exp Cell Res. 1983 Dec;149(2):547-54.

PMID:
6641815
37.

Association of platelet-derived growth factor-induced protein with nuclear material.

Olashaw NE, Pledger WJ.

Nature. 1983 Nov 17-23;306(5940):272-4.

PMID:
6646209
38.

Mitogenic response to epidermal growth factor (EGF) modulated by platelet-derived growth factor in cultured fibroblasts.

Wharton W, Leof E, Olashaw N, O'Keefe EJ, Pledger WJ.

Exp Cell Res. 1983 Sep;147(2):443-8.

PMID:
6352293
39.

Cyclic AMP potentiates down regulation of epidermal growth factor receptors by platelet-derived growth factor.

Leof EB, Olashaw NE, Pledger WJ, O'Keefe EJ.

Biochem Biophys Res Commun. 1982 Nov 16;109(1):83-91. No abstract available.

PMID:
6186250
40.

Increases in cyclic AMP potentiate competence formation in BALB/c-3T3 cells.

Wharton W, Leof EB, Olashaw N, Earp HS, Pledger WJ.

J Cell Physiol. 1982 May;111(2):201-6.

PMID:
6282909
41.

Terminal differentiation in human promyelocytic leukaemic cells in the absence of DNA synthesis.

Rovera G, Olashaw N, Meo P.

Nature. 1980 Mar 6;284(5751):69-70. No abstract available.

PMID:
6928258
42.

Thymidine metabolism in human cells during aging in vitro [proceedings].

Olashaw NE, Grove GL, Cristofalo VJ.

Adv Exp Med Biol. 1978;97:319-20. No abstract available.

PMID:
645486

Supplemental Content

Loading ...
Support Center